2016
DOI: 10.1155/2016/5797232
|View full text |Cite
|
Sign up to set email alerts
|

A Case Report of X-Linked Hyperimmunoglobulin M Syndrome with Lipoma Arborescens of Knees

Abstract: The X-linked hyperimmunoglobulin M syndrome (HIGM), caused by mutations in the CD40LG gene, is a kind of primary immunodeficiency disease (PID). Patients with X-linked HIGM are susceptible to infection as well as autoimmune diseases. Lipoma arborescens (LA) is a rare benign tumor, of which the pathogenesis mechanism has not been clearly understood. We report a case of HIGM combined with LA in a 22-year-old male patient. A new deletion mutation of CD40LG gene was detected in this case. The possible relationship… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
1
1
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 9 publications
0
2
0
1
Order By: Relevance
“…Lipoma arborescens is a rare articular lesion consisting of subsynovial villous proliferation of mature fat cells [1]. Although its exact etiology remains unknown, two types of Lipomas arborescens have been described [2,3]. The primary type is rare, idiopathic and occurs in young patients [4,5].…”
Section: Introductionmentioning
confidence: 99%
“…Lipoma arborescens is a rare articular lesion consisting of subsynovial villous proliferation of mature fat cells [1]. Although its exact etiology remains unknown, two types of Lipomas arborescens have been described [2,3]. The primary type is rare, idiopathic and occurs in young patients [4,5].…”
Section: Introductionmentioning
confidence: 99%
“…[20] CD40LG acts as an immune modulator in activated T cells [21] Inactivation of CD40LG gene resulted from the insertion of an AluYb8 element in exon 1 responsible for a total deficiency of CD40 ligand expression by T lymphocytes [22] Interestingly, some study shows that, not all mutations occur in CD40LG gene may cause XHIGM [23] Different mutations have been reported. [23][24][25][26][27][28][29][30][31][32] As far as we know there are two options for treatment, either hematopoietic stem cell transplantation or intravenous immunoglobulin replacement therapy. [33] but it is sometimes completely ignored because of low recognition and limited knowledge of this rare disease.…”
Section: Introductionmentioning
confidence: 99%
“…Em estudos in vitro, a -amirina apresentou potente atividade frente a diferentes linhagens de células neoplásicas humanas de câncer de cólon, assim como moderada atividade em células de pulmão (DONG;ONO et al, 2004).…”
Section: Figura 47 Estrutura Da Deloxolonaunclassified